Skip to content
Clinical Trials – home

Folinic Acid: A Comprehensive Guide for Patients

47 / 90
trials open to patients / all trials
24+
Countries

In short

Folinic acid, also known as leucovorin or calcium folinate, is being studied in clinical trials for its potential therapeutic effects in several medical conditions. These trials aim to evaluate the safety and efficacy of folinic acid in treating or managing symptoms associated with autism spectrum disorders, cancer-related side effects, and certain neurological disorders. The research explores different dosages, administration methods, and combinations with other treatments to determine optimal use of folinic acid across various patient populations.

At a glance

Main Conditions Studied
Autism Spectrum Disorders, Cancer-related side effects, Hereditary Spastic Paraplegia
Dosage Range
Typically 1-2 mg/kg/day, up to 50 mg/day maximum in some trials
Administration Methods
Oral (pills or liquid), Intravenous infusion
Duration of Treatment
Varies from 12 weeks to several years, depending on the study
Primary Outcome Measures
Language improvement, Reduction of mucositis, Motor function improvement
Secondary Outcome Measures
Social skills, Stereotyped behaviors, Cognitive function, Laboratory indicators
Safety Monitoring
Blood tests, Adverse event reporting, Regular clinical evaluations
Potential Mechanisms
Improving folate metabolism, Reducing oxidative stress, Enhancing cellular function

What is Folinic Acid?

Folinic acid, also known as leucovorin calcium or levoleucovorin, is a form of folic acid, which is an essential B vitamin. It is a reduced form of folate that can be easily used by the body. Folinic acid is important for various bodily functions, including DNA synthesis and repair, which are crucial for normal cell growth and development.

Medical Uses of Folinic Acid

Folinic acid has several medical applications and is being studied for its potential benefits in various conditions:

  • Autism Spectrum Disorder (ASD): Research is ongoing to evaluate the effectiveness of folinic acid in improving symptoms of ASD, particularly language and communication skills.
  • Cancer Treatment: Folinic acid is used in combination with other chemotherapy drugs to treat certain types of cancer, such as colorectal cancer and non-small cell lung cancer.
  • Reducing Chemotherapy Side Effects: It may help reduce the toxic effects of certain chemotherapy drugs.

Folinic Acid in Autism Spectrum Disorder

Several studies are investigating the potential benefits of folinic acid for children with Autism Spectrum Disorder:

  • Improvement in language skills: Some research suggests that folinic acid may help improve both receptive (understanding) and expressive (speaking) language in children with ASD.
  • Social skills and behavior: Studies are looking at whether folinic acid can help improve social interaction and reduce stereotypical behaviors associated with ASD.
  • Adaptive skills: Researchers are examining if folinic acid can enhance adaptive skills, which are everyday living skills that help individuals function independently.

It's important to note that while these studies show promise, more research is needed to fully understand the effects of folinic acid in ASD.

Folinic Acid in Cancer Treatment

Folinic acid plays a significant role in certain cancer treatments:

  • Colorectal Cancer: It is often used in combination with other chemotherapy drugs, such as fluorouracil (5-FU), to enhance the effectiveness of treatment.
  • Non-Small Cell Lung Cancer: Folinic acid is being studied for its potential to reduce side effects of chemotherapy drugs like pemetrexed.
  • Reducing Mucositis: Some studies are investigating whether folinic acid can help prevent or reduce mucositis, a painful inflammation of the mucous membranes that can occur as a side effect of certain cancer treatments.

Dosage and Administration

The dosage and administration of folinic acid can vary depending on the condition being treated and the individual patient. Here are some examples from clinical trials:

  • For ASD: Doses ranging from 2mg/kg per day (maximum 50 mg per day) to 5mg twice a day have been studied.
  • For cancer treatment: Dosages can vary widely and are often based on body surface area. For example, one study used 5 mg/m² given intravenously.

It's crucial to note that folinic acid should only be taken under the supervision of a healthcare provider, who will determine the appropriate dosage based on the specific condition and individual factors.

Potential Benefits

Research suggests that folinic acid may offer several potential benefits:

  • Improved language and communication skills in children with ASD.
  • Enhanced effectiveness of certain chemotherapy treatments.
  • Reduced side effects from some cancer treatments.
  • Possible improvements in social skills and reduction in stereotypical behaviors in ASD.

Ongoing Research

Numerous clinical trials are currently underway to further investigate the potential uses and benefits of folinic acid:

  • Studies on its role in improving symptoms of Autism Spectrum Disorder.
  • Research on its effectiveness in reducing chemotherapy-related side effects.
  • Investigations into its potential to enhance the efficacy of cancer treatments.

As research continues, our understanding of folinic acid and its potential medical applications may expand, potentially leading to new treatments and improved patient outcomes.

Questions people often ask

Conditions where Folinic Acid is being studied

Each condition opens its own overview and trial list

Trials with Folinic Acid

Recruiting trials first

See all 90 →
Quick filters
  • Participants:Adults
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).